Jounce Therapeutics Inc.

10/07/2021 | Press release | Distributed by Public on 10/07/2021 06:04

Jounce Therapeutics Progresses INNATE Study of JTX-8064 (LILRB2/ILT4 Inhibitor) Monotherapy and Pimivalimab (PD-1 Inhibitor) Combination Therapy in Patients with Advanced Solid[...]